FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Initiates Rapport Therapeutics at Outperform With $52 Price Target

By

Rapport Therapeutics (RAPP) has an average rating of buy and mean price target of $58.30, according to analysts polled by FactSet.

What else is happening in Research?